ReviewImmunotherapy2025
Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease.
Tania Dexter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it
ReviewImmunotherapy2025
Tania Dexter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.